Casdin Capital’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $143M | Buy |
|
|||||
|
2025
Q4 | $110M | Buy |
|
|||||
|
2025
Q3 | $59.2M | Sell |
|
|||||
|
2025
Q2 | $39.4M | Buy |
|
|||||
|
2025
Q1 | $23.8M | Buy |
|
|||||
|
2024
Q4 | $36.9M | Sell |
|
|||||
|
2024
Q3 | $65.5M | Buy |
|
|||||
|
2024
Q2 | $55.1M | Buy |
|
|||||
|
2024
Q1 | $61.6M | Buy |
|
|||||
|
2023
Q4 | $81.3M | Buy |
|
|||||
|
2023
Q3 | $58.2M | Buy |
|
|||||
|
2023
Q2 | $75.3M | Buy |
|
|||||
|
2023
Q1 | $93.9M | Buy |
|
|||||
|
2022
Q4 | $45.3M | Sell |
|
|||||
|
2022
Q3 | $105M | Buy |
|
|||||
|
2022
Q2 | $68.1M | Buy |
|
|||||
|
2022
Q1 | $115M | Hold |
|
|||||
|
2021
Q4 | $118M | Buy |
|
|||||
|
2021
Q3 | $116M | Buy |
|
|||||
|
2021
Q2 | $123M | Hold |
|
|||||
|
2021
Q1 | $117M | Sell |
|
|||||
|
2020
Q4 | $158M | Hold |
|
|||||
|
2020
Q3 | $162M | Buy |
|